Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths

NCT01788774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Risperidone ISM 50 mg
DRUG: Risperidone ISM 75 mg
DRUG: Risperidone ISM 100 mg

Sponsor

Rovi Pharmaceuticals Laboratories